A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT00531817 · COMPLETED
Trial details
- NCT number
- NCT00531817
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-06-01
- Enrollment
- 619
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.